It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Food And Drug Administration (FDA) has indicated that the Hemopurifier will be treated as a Class III Medical Device in U.S. regulatory submissions. Pre-clinical human blood studies have documented the effectiveness of the Hemopurifier in capturing HIV (The AIDS Virus), HCV (Hepatitis-C), and Orthopox Viruses related to human Smallpox. The mechanism of capture has been shown to be via the polysaccharide chains that reside on the surface glycoproteins of envelope viruses.
Hemopurifier is presently the only proposed treatment for H5N1 Avian Flu that simultaneously targets the clearance of H5N1 and the modulation of the cytokine storm.
Aethlon is wrapping up safety trials in India and hopes to begin clinical tests in the U.S. by the end of this year.
Originally posted by Jazzyguy
In Popular Science
Why India??
[edit on Thu, 10 Jan 08 by Jazzyguy]
Originally posted by esecallum
Originally posted by esecallum
I am amazed you don't know this
Trouble with this device only viruses that flow through it will be filtered.
Static blood or newly released viruses from lymph nodes will then re-populate the cleaned blood....
SAN DIEGO, April 30, 2009 /PRNewswire-FirstCall via COMTEX/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) confirmed today that the Aethlon Hemopurifier(R) is a candidate to treat the H1N1 Swine flu virus. The Hemopurifier(R) is a first-in-class medical technology that assists the immune response in combating infectious disease through the selective adsorption of circulating viruses and immunosuppressive proteins. In the case of pandemic influenza, the Hemopurifier(R) has previously proven effective in capturing the reconstructed Spanish flu of 1918 virus (1918rv), the H5N1 avian influenza virus (Bird Flu), and would likely capture H1N1 swine flu as the technology selectively captures influenza viruses by hemagglutinin (HA) and neuraminidase (NA) glycoproteins that coat the virus, even when influenza mutates to be resistant against drug and vaccine therapies. As an example, H5N1 bird flu virus was documented to be resistant against Tamiflu, the globally stockpiled antiviral treatment for influenza.